February 12, 2019 10:08 AM EST
News Briefing

Chi­na vows to con­tin­ue speed­ing up drug ap­provals, ex­pand tax cuts; Sor­ren­to/Yuhan JV re­ceives $40M fi­nanc­ing

Amber Tong

→ In the lat­est move to spur in­tro­duc­tion of new med­i­cines, Chi­na has an­nounced it will re­duce the val­ue-add tax on 21 rare …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

Will CRISPR mat­ter?

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times